Navigation Links
CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
Date:8/19/2007

- Enrollment completed in Phase II trial evaluating a single dose of

velafermin for the prevention of severe oral mucositis - - Continued focus to define registrational path for belinostat in the

treatment of cancer - - Conference call and webcast to be held today at 6:00 p.m. Eastern Time -

BRANFORD, Conn., Aug. 6 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, today announced that a conference call will be hosted at 6:00 p.m. Eastern time to provide an update on its clinical pipeline. Dr. Frank Armstrong, President and Chief Executive Officer, and Dr. Timothy Shannon, Executive Vice President and Chief Medical Officer, will provide an update on the Company's clinical programs including:

Velafermin for the prevention of severe oral mucositis (OM):

Enrollment has been completed in the Phase II randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a single infusion of velafermin for the prevention of severe OM. A total of 390 patients at 33 centers were enrolled throughout the United States. Primary safety and efficacy assessments of treated patients will be concluded at participating centers during August with preliminary, top-line efficacy results from the completed trial available in mid-October of 2007. Patients will be followed for an additional year to assess long term outcome with results available during the fourth quarter of 2008. The Phase II trial is designed to assess the reduction in the incidence of severe WHO Grade 3 or 4 OM in patients receiving high-dose chemotherapy, with or without total body irradiation (TBI), prior to autolo
'/>"/>

SOURCE CuraGen Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
5. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
6. XTL Provides Update on Phase I Clinical Trial of XTL-2125
7. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
8. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
9. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
10. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
11. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  CARsgen, a leader in the ... to treat a variety of cancers, today announced the ... a China -based healthcare private equity ... focused on the development of new therapeutics for liver, ... Cancer Institute and Shanghai Renji Hospital, the company plans ...
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
(Date:11/26/2014)... 25, 2014   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will attend The Benchmark Company, LLC,s Micro Cap ... will be held at The Palmer House Hilton, 17 E. ... a.m. to 2:30 p.m. Please email hska@haydenir.com or ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. (AMEX: ... a developer, manufacturer and distributor of botanical products, ... today announced that its wholly owned subsidiary, Harbin ... approval to produce water-based mixtures. The ...
... 12, 2011 Reportlinker.com announces that a new market ... Europe Neurology Devices Market Outlook to 2017 ... Neurology Devices Market Outlook to 2017 ... Devices Market Outlook to 2017" provides key market data ...
Cached Medicine Technology:China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 2Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 4Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 5Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 6Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 7Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 8Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 9Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 10Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 11Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 12Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 13Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 14Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 15Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 16Reportlinker Adds Europe Neurology Devices Market Outlook to 2017 17
(Date:11/27/2014)... (PRWEB) November 27, 2014 Blood-borne pathogens ... many medical precautions and procedures in place to counter ... and disposal of things tainted with menstrual blood are ... design a simpler, more sanitary way to handle tampons ... an inventor from Sonora, Calif. , He then created ...
(Date:11/27/2014)... Dotinga HealthDay Reporter , WEDNESDAY, ... pre-wired to acquire a second language, new research suggests. But ... likely gain a brain boost, the small study finds. ... said study co-author Ping Li, co-director of the Center for ... even more interesting, Li said, that "the brain networks of ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 In ... an inventor from Sharpes, Fla., designed an easy way to ... lowering it/them. , He then created a prototype of the ... lift or lower a toilet seat and/or lid in a ... which prevents the spread of germs. Overall, it promotes good ...
(Date:11/27/2014)... November 27, 2014 Tylenol lawsuits ( ... allegedly injured by the medication are continuing to move ... is looking ahead to a status conference in December, ... Scheduling Order issued earlier this year, a conference in ... at 10:00 a.m. Items likely to be discussed at ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “LAB.C” was ... which features the latest and coolest technology products available to ... conducted the product review and shared with viewers ... for iOS and Android devices. , Consumers love portability and ... Their Cable Case for the iPhone5 and 5S has ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
... be more effective than a "fat" tax for deterring overweight ... study has found. A survey of 364 shoppers in random ... people from reaching for junk food, shoppersincluding those with the ... high fat content and included a note that the item ...
... D.C. It is important that the United States begin to ... APS believes that as a nation we need to be smart ... a clear understanding of what it means for America,s future jeopardizes ... For more than half a century, science and technology have been ...
... (HealthDay News) -- A lack of leptin contributes to the ... of body fat, but treatment with a synthetic form of ... a new study indicates. Extremely low levels of body ... as runners and dancers, and in those with eating disorders. ...
... April 8, 2011 Increased levels of a protein ... a major cardiovascular event in high-risk patients, according to a ... Measuring the amount of the protein, known as plasma renin ... tool to assess a patient,s risk and help prevent a ...
... HealthDay Reporter , THURSDAY, April 7 (HealthDay ... stroke appears to promote arm strength and function, Canadian ... approaches -- including the use of virtual reality [gaming] ... social participation," said lead researcher Dr. Gustavo Saposnik, director ...
... 2011A growing body of research suggests that caffeine disrupts ... poor control of type 2 diabetes, a major public ... of Journal of Caffeine Research : The International ... from Mary Ann Liebert, Inc. publishers, examines the latest ...
Cached Medicine News:Health News:Warning labels better than a fat tax, University of Alberta study shows 2Health News:US House budget plans would jeopardize scientific research facilities 2Health News:Hormone Linked to Absence of Periods in Women With Low Body Fat 2Health News: Video Games Might Aid in Stroke Rehab 2Health News: Video Games Might Aid in Stroke Rehab 3Health News:Caffeine and diabetes -- helpful or harmful? 2
5.5 pointed curved blade. Octagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
2 mm wide curved tip. Round handle....
8 mm downcutting Royce blade. Angled shaft. 60 mm from angle to tip....
Medicine Products: